Feb 22, 2021
Vancouver, Canada (February 22, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce that the Company...
Feb 16, 2021
Vancouver, Canada (February 16, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), and its exclusive German diagnostics development partner,...
Feb 10, 2021
Vancouver, Canada (February 10, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that XPhyto Laboratories...
Feb 3, 2021
Vancouver, Canada (February 3, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that XPhyto Laboratories...
Jan 28, 2021
Construction of commercial drug manufacturing facility in GermanyFour clinical studies in neurological indications in 2021Development of oral biosensor and contract development & manufacturingPsychedelic transdermal and...
Jan 18, 2021
Commercialization of rapid COVID-19 PCR testClinical validation of transdermal and sublingual drug formulationsPsychedelic API production, drug formulation and clinical integration Vancouver, Canada (January 18, 2021)...
Dec 17, 2020
Vancouver, Canada (December 17, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next-generation bioscience accelerator, and its exclusive...
Nov 9, 2020
Psilocybin, mescaline, LSD, MDMA, DMT and other psychedelic compounds added to exclusive dealing agreement for the development of psychedelic-based therapeutics Vancouver, Canada (November 09, 2020)...
Nov 4, 2020
Experienced pharma executive and consultant Per S. Thoresen joins boardAdvisory engagement with CorpCann AS strengthens Europe-focused strategy Vancouver, Canada (November 04, 2020) - XPhyto Therapeutics...
Nov 3, 2020
Research agreement to investigate the feasibility of a proprietary biotechnology process for the industrial production of psilocybin APIPsilocybin is designated by the FDA as a...
Oct 28, 2020
25-minute RT-PCR lab test to complement 15-minute rapid testEuropean market launch of both COVID-19 tests planned for Q1 2021 Vancouver, Canada (October 28, 2020) -...
Oct 19, 2020
Vancouver, Canada (October 19, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), a next-generation bioscience company, is pleased to...
Hear about our latest research, products, exclusive partnerships & more.